Nobutaka Yagi is a senior patient engagement (PE) specialist at Boehringer Ingelheim. In this position, Mr. Yagi is responsible for leading PE activities in Japan, which also include building evidence captured by patient experience data to amplify values of therapeutic options. Mr Yagi is a thought leader of patient and public involvement in Japan, working for PPI JAPAN, a EUPATI's national platform and closely collaborating with PFMD. Mr. Yagi is also the representative director of YORIAILab, an NPO providing the Clinical Trial Ambassador project. Mr. Yagi has 24 years' experience in the pharmaceutical industry. Mr. Yagi holds a MSc in Statistics from Oregon State University, with additional backgrounds in social/behavioral sciences.

Hayley is a healthcare leader with 25+ years of experience turning patient needs into real-world impact. As Executive Director – Operations at Patient Focused Medicines Development (PFMD), she drives strategy and coherence to make patient engagement meaningful, scalable, and systematic. She has led pioneering work on patient experience data, engagement intelligence, and embedding the patient voice in ESG and investment strategies. Based in Canada, with a Master of Health Science from the University of Toronto and lived caregiver experience, Hayley is known for building cross-sector partnerships that bring together biopharma, medtech, regulators, and patient groups to deliver measurable value and better health outcomes

Masanori Okuse is the representative director of The Japanese Association for Psoriatic Disease, and also is a part of the board directors of IFPA, International Federation of Psoriasis Associations, as a patient with psoriatic disease. He formerly worked for pharmaceutical companies and CRO for more than 30 years in total. In the companies, he has a wealth of experience in marketing, medical affairs and clinical trials. He has served as a patient advisor for the Patient Advocacy Committee, PhRMA since 2023.

Project Manager, Center for Promotion of Translational Research, National Cancer Center Japan. 9 years of experience as a clinical research coordinator at university hospitals and other institutions. He has experience in patient-centered care and clinical trial management. Registered dietitian, Master of Nutrition.

Ms. Nobuko Ushirozawa is the Chief of the Research Administration Division at the National Cancer Center Japan (NCC). She oversees research fund management, ensures human reserch protection through the Research Ethics Committee, and supports industry-academia collaboration, enhancing NCC’s research promotion system. Starting her career as a nurse at a university hospital, Ushirozawa has spent 25 years supporting clinical research in various roles, including clinical research coordinator and establishing support organizations for investigator-initiated clinical trials. She also worked at the Ministry of Health, Labour and Welfare, promoting policies to revitalize clinical trials.

Tatsuro HOSHINO is principal reviewer in Office of New Drug ?, Pharmaceuticals and Medical Devices Agency (PMDA).He is also a member of the Patient Centricity Working Group.